Literature DB >> 16282570

Long-term prediction of mortality in elderly persons by dobutamine stress echocardiography.

Elena Biagini1, Abdou Elhendy, Arend F L Schinkel, Vittoria Rizzello, Jeroen J Bax, Fabiola B Sozzi, Miklos D Kertai, Ron T van Domburg, Boudewijn J Krenning, Angelo Branzi, Claudio Rapezzi, Maarten L Simoons, Don Poldermans.   

Abstract

BACKGROUND: Dobutamine stress echocardiography (DSE) was shown to provide incremental prognostic information. However, its role in the prediction of mortality in elderly persons is not well defined. We assessed the value of DSE in the prediction of mortality and hard cardiac events during long-term follow-up in patients older than 65 years.
METHODS: We studied 1434 patients >65 years old (mean age 72 +/- 3 years) who underwent DSE for evaluation of coronary artery disease. Ischemia was defined as new or worsening wall motion abnormalities. Follow-up events were total mortality and hard cardiac events (cardiac mortality and nonfatal myocardial infarction). Multivariable Cox regression analysis was used to identify the independent predictors of follow-up events.
RESULTS: Ischemia was detected in 675 patients (47%). Five hundred six patients (35%) had a normal study, and 253 (18%) had fixed wall motion abnormalities. During a mean follow-up of 6.5 years, 532 (37%) deaths occurred, of which 249 (17%) were due to cardiac causes. A nonfatal myocardial infarction occurred in 45 patients (3%). Independent predictors of all-cause mortality in a multivariate analysis model were age (hazard ratio [HR] 1.06; 95% confidence interval [CI], 1.05-1.08), male sex (HR 1.5; 95% CI, 1.2-1.8), hypertension (HR 1.2; 95% CI, 1.1-1.4), smoking (HR 1.3; 95% CI, 1.1-1.6), diabetes (HR 1.4; 95% CI, 1.1-1.8), rest wall motion abnormalities (HR 1.07; 95% CI, 1.06-1.09), and ischemia (HR 1.3; 95% CI, 1.1-1.6). Independent predictors of hard cardiac events were age (HR 1.07; 95% CI, 1.05-1.09), male sex (HR 1.3; 95% CI, 1.1-1.7), smoking (HR 1.3; 95% CI, 1.1-1.6), diabetes (HR 1.6; 95% CI, 1.2-2.2), rest wall motion abnormalities (HR 1.13; 95% CI, 1.12-1.16), and ischemia (HR 2.1; 95% CI, 1.5-2.8).
CONCLUSION: DSE provides independent prognostic information to predict all-cause mortality and hard cardiac events in elderly patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282570     DOI: 10.1093/gerona/60.10.1333

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  6 in total

1.  Prognostic value of dobutamine stress echocardiography in octogenarians.

Authors:  Francesca Innocenti; Arianna Totti; Caterina Baroncini; Francesco Fattirolli; Costanza Burgisser; Riccardo Pini
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-30       Impact factor: 2.357

Review 2.  Dobutamine stress echocardiography: does it predict response to beta-blockers in patients with heart failure?

Authors:  Sripal Bangalore; Khashayar Hematpour; Farooq A Chaudhry
Journal:  Curr Heart Fail Rep       Date:  2006-06

Review 3.  Stress echocardiography for the detection and assessment of coronary artery disease.

Authors:  Nowell M Fine; Patricia A Pellikka
Journal:  J Nucl Cardiol       Date:  2011-05       Impact factor: 5.952

4.  Left ventricular cavity obliteration during dobutamine stress echocardiography in diabetic patients.

Authors:  Francesca Innocenti; Caterina Baroncini; Chiara Agresti; Edoardo Mannucci; Matteo Monami; Riccardo Pini
Journal:  Int J Cardiovasc Imaging       Date:  2011-07-06       Impact factor: 2.357

5.  Native cardiac reserve predicts survival in acute post infarction heart failure in mice.

Authors:  Margareta Scharin Täng; Truls Råmunddal; Malin Lindbom; Elmir Omerovic
Journal:  Cardiovasc Ultrasound       Date:  2007-12-02       Impact factor: 2.062

6.  The prognostic value of dobutamine stress echocardiography amongst British Indian Asian and Afro-Caribbean patients: a comparison with European white patients.

Authors:  Jamie M O'Driscoll; Claire Rossato; Paula Gargallo-Fernandez; Marco Araco; Dimitrios Giannoglou; Sanjay Sharma; Rajan Sharma
Journal:  Cardiovasc Ultrasound       Date:  2015-08-06       Impact factor: 2.062

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.